Jnj financials morningstar

Find the latest Financials data for Johnson & Johnson Common Stock (JNJ) at Nasdaq.com.

Morningstar Management Behind the Moat Conference. 9 November 2011. Thomas Kudsk Larsen. Head of Investor Relations North America  JNJ's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing. Review JNJ revenue, net income, and cash flow. Start a 14-day free trial to Morningstar Premium to unlock full historical financials. Learn about JNJ with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on JNJ. Review JNJ dividend yield and history, to decide if JNJ is the best investment for you. Personal Finance Save for College Save for Retirement JNJ Morningstar Rating Rating as of Mar 13, 2020. Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing.

Johnson & Johnson. JNJ Morningstar Rating. Rating as of Mar 13, 2020. Quote · Stock Analysis · News · Price vs Fair Value · Trailing Returns · Financials 

Learn about JNJ with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on JNJ. Review JNJ dividend yield and history, to decide if JNJ is the best investment for you. Personal Finance Save for College Save for Retirement JNJ Morningstar Rating Rating as of Mar 13, 2020. Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing. Personal Finance Save for College JNJ Morningstar Rating Rating as of Mar 13 Johnson & Johnson Announces Collaboration with the Beth Israel Deaconess Medical Center to Accelerate COVID-19 Corporate Reports Here are some of the print and digital publications we produce each year that recap the company’s business performance and key enterprise-wide milestones. 2020 Annual Meeting Materials

JNJ has a Effective Interest Rate on Debt % of 1.19% as of today(2020-03-06). In depth view into Johnson & Johnson Effective Interest Rate on Debt 

Johnson & Johnson. JNJ Morningstar Rating. Rating as of Mar 13, 2020. Quote · Stock Analysis · News · Price vs Fair Value · Trailing Returns · Financials  Data provided by Morningstar, Inc. 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares  Equity ETFs · Technology ETFs · Financials ETFs · Emerging Markets ETFs The following ETFs maintain exposure to Johnson & Johnson (JNJ). 177 ETFs have Johnson & Johnson within its Top 15 holdings as displayed below. JKF · iShares Morningstar Large-Cap Value ETF · Large Cap Value Equities, 0.25%, 6.70 

4 Feb 2017 Adobe 86% http://financials.morningstar.com/ratios/r.html?t=ADBE Johnson & Johnson 69% http://financials.morningstar.com/ratios/r.html?t= 

Learn about JNJ with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar   The 17 analysts offering 12-month price forecasts for Johnson & Johnson have a median target of 163.00, with a high estimate of 173.00 and a low estimate of 

3 dagen geleden index nu consumentengoederen, industrie, financials en grondstoffen. JP Morgan Chase en Johnson & Johnson zijn fair gewaardeerd en 

You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.

Find real-time JNJ - Johnson & Johnson stock quotes, company profile, news and forecasts from CNN Business. JNJ - Johnson & Johnson Stock quote - CNNMoney.com Markets The Investor Relations website contains information about Johnson & Johnson's business for stockholders, potential investors, and financial analysts. Quarterly Results | Johnson & Johnson Skip to main navigation